Aerolase

Aerolase is a U.S.-based medical laser company dedicated to advancing the science and practice of laser medicine through proprietary pulse duration technology. Founded in 1996, Aerolase has built its reputation on engineering precision — developing devices that prioritize patient safety, clinical efficacy, and practitioner confidence across the full spectrum of skin types and conditions.

At the core of Aerolase's technology is its proprietary 650-microsecond pulse duration, which sets it apart from conventional laser platforms. This ultra-short pulse delivery minimizes heat buildup in surrounding tissue, dramatically reducing the risk of post-inflammatory hyperpigmentation (PIH), burns, and adverse events — making Aerolase devices among the most inclusive laser platforms available for patients with Fitzpatrick skin types IV through VI.

Flagship Devices

Aerolase's product portfolio is anchored by three clinical platforms:

• Neo Elite — A 1064nm Nd:YAG laser delivering the 650-microsecond pulse, indicated for acne, rosacea, melasma, PIH, psoriasis, onychomycosis, hair removal, skin rejuvenation, and vascular conditions. Its inflammation-targeting mechanism makes it uniquely effective across diverse patient populations.
• Era Elite — A 2940nm Er:YAG ablative resurfacing platform featuring a 300-microsecond pulse duration, engineered for skin resurfacing, scar revision, and skin tightening with reduced downtime and improved safety margins compared to conventional ablative lasers.
• Exci308 — A 308nm excimer laser developed for targeted phototherapy of autoimmune and pigmentary skin conditions including vitiligo, psoriasis, atopic dermatitis, and alopecia areata.

Clinical Philosophy

Aerolase's clinical approach is grounded in treating the root causes of skin disease rather than surface-level symptoms. The company has championed an inflammation-first framework — particularly relevant in conditions like acne, rosacea, and PIH — where addressing the inflammatory cascade upstream leads to more durable, comprehensive outcomes for patients. This philosophy informs both device design and the continuing medical education Aerolase provides to the practitioner community.

Commitment to Skin of Color

Aerolase has been a consistent advocate for equitable laser care. At a time when many laser platforms carry elevated risk for melanin-rich skin, Aerolase's technology was engineered from the ground up to be safe and effective for patients of all skin tones. The company actively partners with leading dermatologists specializing in skin of color to advance clinical research, education, and awareness in this historically underserved space.

Practitioner Community & Education

Aerolase supports a global network of dermatologists, plastic surgeons, and aesthetic practitioners through clinical training, key opinion leader (KOL) partnerships, peer-reviewed research, and continuing education programs including live and on-demand webinars. The company's KOL network includes recognized experts in medical dermatology, cosmetic dermatology, and procedural aesthetics who contribute to advancing the evidence base for Aerolase technologies.

Global Reach

Aerolase devices are used in clinical and aesthetic practices across North America, Europe, Asia, and beyond. The company continues to expand its international footprint while maintaining its roots as an independent, innovation-driven organization committed to the highest standards of medical device engineering.